Leerink Partners Cuts Price Target on Endologix (ELGX) to $8 Following Analyst Day

November 18, 2016 7:20 AM EST
Get Alerts ELGX Hot Sheet
Price: $6.97 -1.13%

Rating Summary:
    13 Buy, 4 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 28 | Down: 20 | New: 17
Trade ELGX Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Leerink Partners maintained a Market Perform rating on Endologix (NASDAQ: ELGX), and cut the price target to $8.00 (from $11.00), following the company's analyst day. The focus of the presentation was around Nellix. There was news on Wednesday that potential approval has been pushed out ~6 months. This comes following a request for additional info from the FDA. Management also updated 2016 revenue guidance to $198-$200M (vs. $198-$201M prior) as ELGX anticipates more limited Nellix usage in Europe following its label change to a narrower IFU.

Analyst Ravi Misra commented, "We remain MP on ELGX following the company's analyst day at the VEITH symposium. The focus was understandably around Nellix given now narrower instructions for use (IFU) and Wednesday's (11/16) news that potential approval has been pushed out ~6 months given a request for additional info from the FDA. Nellix remains the company's key growth driver and while we continue to believe the device will receive FDA approval (now a potential 2Q18 event vs. 4Q17 prior) the narrower indication is expected to have a negative ripple effect on sales to existing users in Europe that further reinforces our view that meaningful Nellix driven upside to estimates is unlikely. As a result, mgmt also lowered the top end of '16 rev. guidance by $1M as European clinicians begin to adjust usage, and this is expected to have an impact into '17 as well. As a result, our estimates and multiple move lower and PT is reduced to $8 (vs. $11)."

For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.

Shares of Endologix closed at $7.81 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Add Your Comment